D Concordet
Levothyrox® new and old formulations: are they switchable for millions of patients?
Concordet, D; Gandia, P; Montastruc, J L; Bousquet-Mélou, A; Lees, P; Ferran, A; Toutain, P L
Authors
P Gandia
J L Montastruc
A Bousquet-Mélou
P Lees
A Ferran
P L Toutain
Citation
Concordet, D., Gandia, P., Montastruc, J. L., Bousquet-Mélou, A., Lees, P., Ferran, A., & Toutain, P. L. (2019). Levothyrox® new and old formulations: are they switchable for millions of patients?. Clinical Pharmacokinetics, https://doi.org/10.1007/s40262-019-00747-3
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 4, 2019 |
Publication Date | Apr 4, 2019 |
Deposit Date | Jan 25, 2019 |
Publicly Available Date | May 15, 2019 |
Journal | Clinical Pharmacokinetics |
Print ISSN | 0312-5963 |
Publisher | Adis |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s40262-019-00747-3 |
Public URL | https://rvc-repository.worktribe.com/output/1382869 |
Files
11897.pdf
(572 Kb)
PDF
11897_pub.pdf
(756 Kb)
PDF
You might also like
Biased computation of Probability of Target Attainment for antimicrobial drugs
(2023)
Journal Article
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
(2022)
Journal Article